Aggressive recurrent respiratory papillomatosis: A series of five consecutive patients successfully treated with adjuvant intravenous bevacizumab. A single Belgian academic center experience.
- Resource Type
- Article
- Source
- Head & Neck; May2023, Vol. 45 Issue 5, p1071-1079, 9p
- Subject
PAPILLOMAVIRUS diseases HUMAN papillomavirus BEVACIZUMAB VASCULAR endothelial growth factors TREATMENT effectiveness VOICE disorders WARTS - Language
- ISSN
- 10433074